Medicine for the Public 2001 lecture seriesVideos of the 2001 series will be available online after each lecture.
|
|
New therapies. Innovations in diagnostic procedures. How today's research will affect tomorrow's medicine. Physician-scientists working at the forefront of medical research at the National Institutes of Health will examine these issues during the 2001 Medicine for the Public lecture series sponsored by the NIH Clinical Center. For details on specific topics and speakers, please call (301) 496-2563. Or e-mail occc@cc.nih.gov. |
The lectures,
which are free and open to the public, are presented at
7 p.m. on Tuesdays in the Clinical Center's Masur Auditorium,
National Institutes of Health, 9000 Rockville Pike, Building 10, Bethesda,
Maryland. Booklets based on selected Medicine for the Public lectures are available. Visit this site to order or call 301-496-2563. |
Videos of these lectures require the latest version of RealPlayer. |
||
Sept.
25, 2001 |
00
|
Dr.
Ann Berger will discuss how medicine works with other disciplines
to care for the whole person to ease suffering during serious illness.
|
Oct. 2, 2001 |
00
|
Every
year, about 12 million people acquire sexually transmitted diseases. These
diseases lead to multiple complications, including infertility, ectopic
pregnancies, chronic pain, and cancer. Most cases can be cured. All of
them can be prevented. Dr. Thomas Quinn
will discuss the incidence, the costs, the impact on society, and what
can be done to decrease the risk of sexually transmitted diseases.
|
Oct.
9, 2001
New Strategies for the Detection and Treatment of Colon Cancer Steven Libutti, M.D. Senior Investigator, Surgery Branch National Cancer Institute |
00
|
Colon
cancer strikes 130 thousand people a year. It is the second leading cause
of cancer death in the United States, and has a mortality rate of nearly
50 percent. Dr. Steven Libutti will
discuss how it is detected and treated. He will also discuss what new
detection and treatment options are currently under study to increase
survival, including local ablative therapy, anti-angiogenic therapy, and
new ways to deliver chemotherapy.
|
Oct. 16, 2001 |
00
|
Dr.
Zujewski will discuss the risk factors for developing breast cancer
and discuss current treatment options. She will review progress made in
this disease and look at promising new research directions.
|
Oct. 23, 2001 |
00
|
Sixteen
million people in the United States have diabetes; one million of them
have type 1. It is the sixth leading cause of death in this country and
often leads to blindness, heart and blood vessel disease, strokes, kidney
failure, amputations, and nerve damage. Dr.
David Harlan, will discuss the difference between type 1 and type
2 diabetes, then will focus on advances in how physicians might treat
type 1 diabetes. HeÕll emphasize the latest research using islet transplantation
and some other positive milestones to date.
|
Oct.
30, 2001 |
00
|
About
10 to 20 percent of Americans are infected with the influenza virus each
year. For most, the aches and pains associated with the flu come and go
within a couple of weeks. However, an estimated 100,000 people are hospitalized
and 20,000 deaths occur annually from the flu and its complications. Dr.
Brian Murphy will explore the latest findings in flu vaccines, including
a new influenza virus vaccine undergoing evaluation by the Food and Drug
Administration.
|
Past lectures:
2005 | 2004 |
2003 | 2002 |
2001 | 2000 |
1999 | 1998 |
1997
Back to most current lectures
For
more information about the Clinical Center,
e-mail occc@cc.nih.gov, or call
Clinical Center Communications, 301-496-2563.
Warren
Grant Magnuson Clinical Center
National Institutes of Health
Bethesda, Maryland 20892-7511